No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Atelvia is a brand of Endocrine and Metabolic Disorders Drugs used to treat osteoporosis. It is a bisphosphonate, a type of drug that helps to reduce the risk of fractures by increasing bone mineral density. Atelvia is taken orally once a month and is available in both tablet and capsule form. It is used to treat postmenopausal women with osteoporosis, as well as men and premenopausal women with low bone mineral density.
Atelvia is part of a larger market of Endocrine and Metabolic Disorders Drugs, which includes other bisphosphonates, hormone replacement therapies, and other medications. These drugs are used to treat a variety of conditions, including osteoporosis, diabetes, and thyroid disorders.
The Atelvia market is highly competitive, with several major pharmaceutical companies offering their own brands of bisphosphonates. Some of these companies include Merck, Pfizer, Novartis, and Amgen. Show Less Read more
